Current Report Filing (8-k)

Date : 05/09/2019 @ 9:05PM
Source : Edgar (US Regulatory)
Stock : Vaxart, Inc. (VXRT)
Quote : 0.7177  0.0157 (2.24%) @ 1:00AM

Current Report Filing (8-k)

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): Ma y 9 , 201 9

 

 

Vaxart, Inc.

(Exact name of registrant as specified in its charter)

 

 

         

Delaware

 

001-35285

 

59-1212264

(State or other jurisdiction   of incorporation)

 

(Commission   File Number)

 

(IRS Employer   Identification No.)

   

290 Utah Ave. Suite 200   South San Francisco, California

 

94080

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: ( 650) 550-3500

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 

 

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 

 

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging Growth Company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading symbol

 

Name of each exchange on which registered

Common stock, $0.10 par value

 

VXRT

 

Nasdaq Capital Market

 

 

 

 

 

Item 2.02.

Results of Operations and Financial Condition.

 

On May 9, 2019, Vaxart, Inc. issued a press release announcing its financial results for the quarter ended March 31, 2019. A copy of this press release is furnished as Exhibit 99.1 to this report and is incorporated herein by reference.

 

The information in this report, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained herein and in the accompanying Exhibit 99.1 shall not be deemed incorporated by reference into any filing with the U.S. Securities and Exchange Commission made by Vaxart, Inc., whether made before or after the date hereof regardless of any general incorporation language in such filing.

 

Item 9.01.

Financial Statements and Exhibits.

 

(d) Exhibits

 

     

Exhibit

 

Description

   

99.1

 

Press release, dated May 9, 2019, titled “Vaxart Announces First Quarter 2019 Financial Results and Provides Corporate Update”.

 


 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

             
 

 

 

 

Vaxart, Inc.

     

Dated: May 9, 2019

 

 

 

 
       
 

 

 

 

By:

 

/s/ Wouter W. Latour, M.D.

 
 

 

 

 

 

 

Wouter W. Latour, M.D.

 

 

 

 

 

 

President and Chief Executive Officer

 

Vaxart, Inc. (NASDAQ:VXRT)
Historical Stock Chart

1 Year : From Jul 2018 to Jul 2019

Click Here for more Vaxart, Inc. Charts.

Vaxart, Inc. (NASDAQ:VXRT)
Intraday Stock Chart

Today : Sunday 21 July 2019

Click Here for more Vaxart, Inc. Charts.

Latest VXRT Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.